RubrYc Therapeutics Completes $10M Million Series A Financing

SAN RAMON, Calif., April 11, 2018 -- (Healthcare Sales & Marketing Network) -- RubrYc Therapeutics, Inc., a biotherapeutics discovery business, announced today it has closed a $10 million Series A Preferred Equity financing round led by Third Point Ventur... Biopharmaceuticals, Venture Capital RubrYc Therapeutics
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news